SCHEMBL16810345

SCHEMBL16810345

COC(=O)c1ccc(/C=C/C(=O)c2ccco2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 1.00
MAPT P10636 9/20 0.63
RAB9A P51151 6/20 0.63
KMT2A Q03164 5/20 0.63
LMNA P02545 4/20 0.63
MEN1 O00255 4/20 0.63
PSMD14 O00487 2/20 0.63
CRHBP P24387 1/20 0.63
CRHR2 Q13324 1/20 0.63
NPC1 O15118 6/20 0.60
CAPN1 P07384 1/20 0.60
CTSB P07858 1/20 0.60
HTT P42858 2/20 0.59
MAOA P21397 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.57
TP53 P04637 1/20 0.57
ATM Q13315 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CACNA1B Q00975 1/20 0.54
APBA1 Q02410 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18070719 0.83 MAOB (0.71) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL1820821 0.83 MAOB (0.73) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL5598204 0.83 MAOB (0.73) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL18906024 0.82 MAPT (0.70) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL16810263 0.81 MAPT (0.73) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL1321556 0.80 MAPT (0.75) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL1321557 0.80 MAPT (0.75) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL5597968 0.79 MAPT (0.74) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL979280 0.79 MAPT (0.79) MAOBMAPTRAB9AKMT2ALMNA
SCHEMBL2053346 0.79 MAPT (0.79) MAOBMAPTRAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066398-B2 Small molecule c-Myc inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2021-07-20 US disclosed
US-20160264560-A1 SMALL MOLECULE C-MYC INHIBITORS SORRENTO THERAPEUTICS, INC. 2016-09-15 US disclosed
US-20160264560-A1 SMALL MOLECULE C-MYC INHIBITORS SORRENTO THERAPEUTICS, INC. 2016-09-15 US disclosed
WO-2015089180-A1 SMALL MOLECULE C-MYC INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2015-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264560-A1 SMALL MOLECULE C-MYC INHIBITORS MYC, MYCBP, MYCBP2 MAOB 3957/4885MAPT 1202/4885RAB9A 2195/4885
US-11066398-B2 Small molecule c-Myc inhibitors MYC, MYCBP, MYCBP2 MAOB 3957/4885MAPT 1202/4885RAB9A 2195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.